Loading...

Home
ETF
BDRX

BDRX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

BDRX News

Biodexa Pharmaceuticals Raises $3.5 Million Through Offerings

Jul 01 2026NASDAQ.COM

Biodexa Pharmaceuticals Annual General Meeting Results

Jun 30 2026Newsfilter

Biodexa Receives Health Canada Approval to Expand FAP Trial

Jun 29 2026Newsfilter

Biodexa Pharmaceuticals Postpones Annual General Meeting

Jun 17 2026Newsfilter

Biodexa Issues Shareholder Letter on Capital Reorganization

May 14 2026Newsfilter

Biodexa Partners with Syngene, Shares Surge 69%

Apr 02 2026NASDAQ.COM

Biodexa Partners with Syngene for MTX240 GMP Supplies

Apr 02 2026Newsfilter

Biodexa Pharmaceuticals Reports Preliminary Results for 2025

Mar 27 2026Newsfilter

Biodexa Pharmaceuticals Adjusts ADR Ratio

Mar 18 2026seekingalpha

Biodexa Supports Life's a Polyp Foundation for FAP Patients

Mar 09 2026Newsfilter

Biodexa Secures Exclusive License for Otsuka's OPB-171775, a Novel GIST Treatment

Feb 04 2026Newsfilter

Biodexa Pharmaceuticals Appoints Fiona Sharp as CFO, Shares Rise 3.45%

Jan 05 2026NASDAQ.COM

B. Riley Financial Shares Surge Approximately 25%; Check Out 20 Stocks Making Moves in Premarket Trading

Dec 16 2025Benzinga

Mama's Creations Stock Rises Over 13%; Check Out 20 Stocks Making Moves in Premarket Trading

Dec 09 2025Benzinga

Biodexa Activates First European Site for Phase 3 Serenta Trial in FAP

Nov 24 2025Newsfilter

Biodexa Pharmaceuticals submits $100M shelf registration for versatile securities sales

Sep 26 2025SeekingAlpha